US 12029708 — Patent Expiration

ALKOXY COMPOUNDS FOR DISEASE TREATMENT

Shareable link — bookmark or send to anyone

www.patentreply.ai/tools/patent-expiration/US12029708

Important: This calculator does not include patent term extension under 35 U.S.C. § 156, which may apply to certain drug, biologic, animal drug, and medical device patents.

Learn how PTE is calculated

US 12029708

Alkoxy Compounds For Disease Treatment

High Confidence

Application No. 17817927

October 3, 2028

2y 41d remaining

Earliest effective filing

Oct 3, 2008

+ 20 years

Oct 3, 2028

PTA +0d

Oct 3, 2028

TD applied

Oct 3, 2028

Final

Oct 3, 2028

This calculation includes Patent Term Adjustment (PTA) under 35 U.S.C. §154(b). Patent Term Extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Note: terminal disclaimers can affect PTA (In re Cellect, LLC).

Calculation Details

Base Term Calculation

Filing Date

August 5, 2022

Earliest Effective Filing

October 3, 2008

Issue Date

July 9, 2024

PTA

0 days

Base Expiry (before PTA)

October 3, 2028

October 3, 2008 + 20 years = October 3, 2028

Continuation of application 16865195, filed May 1, 2020, issued as US 11446261

Continuation of application 16043019, filed Jul 23, 2018, issued as US 10639286

Continuation of application 15672031, filed Aug 8, 2017, issued as US 10188615

Continuation of application 15260127, filed Sep 8, 2016, issued as US 9737496

Continuation of application 14631763, filed Feb 25, 2015, issued as US 9458088

Continuation of application 13111679, filed May 19, 2011, issued as US 8981153

Continuation of application 12287039, filed Oct 3, 2008, issued as US 7982071

Continuation of application 14631779, filed Feb 25, 2015

Continuation of application 13111679, filed May 19, 2011, issued as US 8981153

Continuation of application 12287039, filed Oct 3, 2008, issued as US 7982071

Continuation of application 13111679, filed May 19, 2011, issued as US 8981153

Continuation of application 12287039, filed Oct 3, 2008, issued as US 7982071

Continuation of application 14631763, filed Feb 25, 2015, issued as US 9458088

Continuation of application 14631779, filed Feb 25, 2015

Continuation of application 13111679, filed May 19, 2011, issued as US 8981153

Continuation of application 12287039, filed Oct 3, 2008, issued as US 7982071

Continuation of application 15260127, filed Sep 8, 2016, issued as US 9737496

Continuation of application 14631763, filed Feb 25, 2015, issued as US 9458088

Continuation of application 14631779, filed Feb 25, 2015

Continuation of application 13111679, filed May 19, 2011, issued as US 8981153

Continuation of application 12287039, filed Oct 3, 2008, issued as US 7982071

Continuation of application 15672031, filed Aug 8, 2017, issued as US 10188615

Continuation of application 15260127, filed Sep 8, 2016, issued as US 9737496

Continuation of application 14631763, filed Feb 25, 2015, issued as US 9458088

Continuation of application 14631779, filed Feb 25, 2015

Continuation of application 13111679, filed May 19, 2011, issued as US 8981153

Continuation of application 12287039, filed Oct 3, 2008, issued as US 7982071

Continuation of application 16043019, filed Jul 23, 2018, issued as US 10639286

Continuation of application 15672031, filed Aug 8, 2017, issued as US 10188615

Continuation of application 15260127, filed Sep 8, 2016, issued as US 9737496

Continuation of application 14631763, filed Feb 25, 2015, issued as US 9458088

Continuation of application 14631779, filed Feb 25, 2015

Continuation of application 13111679, filed May 19, 2011, issued as US 8981153

Continuation of application 12287039, filed Oct 3, 2008, issued as US 7982071

PRO

60977957 — Provisional — not used for base term

PRO

61066353 — Provisional — not used for base term

PRO

61043127 — Provisional — not used for base term

PRO

61051657 — Provisional — not used for base term

PRO

61060083 — Provisional — not used for base term

PRO

60977957 — Provisional — not used for base term

PRO

61066353 — Provisional — not used for base term

PRO

61043127 — Provisional — not used for base term

PRO

61051657 — Provisional — not used for base term

PRO

61060083 — Provisional — not used for base term

PRO

61060083 — Provisional — not used for base term

PRO

61051657 — Provisional — not used for base term

PRO

61043127 — Provisional — not used for base term

PRO

61066353 — Provisional — not used for base term

PRO

60977957 — Provisional — not used for base term

PRO

61060083 — Provisional — not used for base term

PRO

61051657 — Provisional — not used for base term

PRO

61043127 — Provisional — not used for base term

PRO

61066353 — Provisional — not used for base term

PRO

60977957 — Provisional — not used for base term

PRO

60977957 — Provisional — not used for base term

PRO

61066353 — Provisional — not used for base term

PRO

61051657 — Provisional — not used for base term

PRO

61043127 — Provisional — not used for base term

PRO

61060083 — Provisional — not used for base term

PRO

60977957 — Provisional — not used for base term

PRO

61066353 — Provisional — not used for base term

PRO

61051657 — Provisional — not used for base term

PRO

61043127 — Provisional — not used for base term

PRO

61060083 — Provisional — not used for base term

PRO

60977957 — Provisional — not used for base term

PRO

61066353 — Provisional — not used for base term

PRO

61051657 — Provisional — not used for base term

PRO

61043127 — Provisional — not used for base term

PRO

61060083 — Provisional — not used for base term

PRO

60977957 — Provisional — not used for base term

PRO

61066353 — Provisional — not used for base term

PRO

61051657 — Provisional — not used for base term

PRO

61043127 — Provisional — not used for base term

PRO

61060083 — Provisional — not used for base term

PRO

60977957 — Provisional — not used for base term

PRO

61066353 — Provisional — not used for base term

PRO

61051657 — Provisional — not used for base term

PRO

61043127 — Provisional — not used for base term

PRO

61060083 — Provisional — not used for base term

Terminal Disclaimer Analysis

TD Approved

1 approved, 3 filed

TD caps expiration to October 3, 2028

US 9957224(App. 13887243)

Capping Patent

Methods For The Treatment Of Diabetic Retinopathy And Other Ophthalmic Diseases

Filing Date

May 3, 2013

Earliest Effective Filing

May 3, 2013

Issue Date

May 1, 2018

PTA

0 days

Calculated Expiration

May 3, 2033

May 3, 2013 + 20y = May 3, 2033

US 12029708(App. 17817927)(from app 17817927)

Capping Patent

Alkoxy Compounds For Disease Treatment

Filing Date

Aug 5, 2022

Earliest Effective Filing

Oct 3, 2008

Issue Date

Jul 9, 2024

PTA

0 days

Calculated Expiration

Oct 3, 2028

Continuation of 16865195, filed May 1, 2020, issued as US 11446261

Continuation of 16043019, filed Jul 23, 2018, issued as US 10639286

Continuation of 15672031, filed Aug 8, 2017, issued as US 10188615

Continuation of 15260127, filed Sep 8, 2016, issued as US 9737496

Continuation of 14631763, filed Feb 25, 2015, issued as US 9458088

Continuation of 13111679, filed May 19, 2011, issued as US 8981153

Continuation of 12287039, filed Oct 3, 2008, issued as US 7982071

Continuation of 14631779, filed Feb 25, 2015

Continuation of 13111679, filed May 19, 2011, issued as US 8981153

Continuation of 12287039, filed Oct 3, 2008, issued as US 7982071

Continuation of 13111679, filed May 19, 2011, issued as US 8981153

Continuation of 12287039, filed Oct 3, 2008, issued as US 7982071

Continuation of 14631763, filed Feb 25, 2015, issued as US 9458088

Continuation of 14631779, filed Feb 25, 2015

Continuation of 13111679, filed May 19, 2011, issued as US 8981153

Continuation of 12287039, filed Oct 3, 2008, issued as US 7982071

Continuation of 15260127, filed Sep 8, 2016, issued as US 9737496

Continuation of 14631763, filed Feb 25, 2015, issued as US 9458088

Continuation of 14631779, filed Feb 25, 2015

Continuation of 13111679, filed May 19, 2011, issued as US 8981153

Continuation of 12287039, filed Oct 3, 2008, issued as US 7982071

Continuation of 15672031, filed Aug 8, 2017, issued as US 10188615

Continuation of 15260127, filed Sep 8, 2016, issued as US 9737496

Continuation of 14631763, filed Feb 25, 2015, issued as US 9458088

Continuation of 14631779, filed Feb 25, 2015

Continuation of 13111679, filed May 19, 2011, issued as US 8981153

Continuation of 12287039, filed Oct 3, 2008, issued as US 7982071

Continuation of 16043019, filed Jul 23, 2018, issued as US 10639286

Continuation of 15672031, filed Aug 8, 2017, issued as US 10188615

Continuation of 15260127, filed Sep 8, 2016, issued as US 9737496

Continuation of 14631763, filed Feb 25, 2015, issued as US 9458088

Continuation of 14631779, filed Feb 25, 2015

Continuation of 13111679, filed May 19, 2011, issued as US 8981153

Continuation of 12287039, filed Oct 3, 2008, issued as US 7982071

Oct 3, 2008 + 20y = Oct 3, 2028

US 11446261(App. 16865195)

Alkoxy Compounds For Disease Treatment

Filing Date

May 1, 2020

Earliest Effective Filing

Oct 3, 2008

Issue Date

Sep 20, 2022

PTA

0 days

Calculated Expiration

Oct 3, 2028

Continuation of 16043019, filed Jul 23, 2018, issued as US 10639286

Continuation of 15672031, filed Aug 8, 2017, issued as US 10188615

Continuation of 15260127, filed Sep 8, 2016, issued as US 9737496

Continuation of 14631763, filed Feb 25, 2015, issued as US 9458088

Continuation of 13111679, filed May 19, 2011, issued as US 8981153

Continuation of 12287039, filed Oct 3, 2008, issued as US 7982071

Continuation of 14631779, filed Feb 25, 2015

Continuation of 13111679, filed May 19, 2011, issued as US 8981153

Continuation of 12287039, filed Oct 3, 2008, issued as US 7982071

Continuation of 13111679, filed May 19, 2011, issued as US 8981153

Continuation of 12287039, filed Oct 3, 2008, issued as US 7982071

Continuation of 14631763, filed Feb 25, 2015, issued as US 9458088

Continuation of 14631779, filed Feb 25, 2015

Continuation of 13111679, filed May 19, 2011, issued as US 8981153

Continuation of 12287039, filed Oct 3, 2008, issued as US 7982071

Continuation of 15260127, filed Sep 8, 2016, issued as US 9737496

Continuation of 14631763, filed Feb 25, 2015, issued as US 9458088

Continuation of 14631779, filed Feb 25, 2015

Continuation of 13111679, filed May 19, 2011, issued as US 8981153

Continuation of 12287039, filed Oct 3, 2008, issued as US 7982071

Continuation of 15672031, filed Aug 8, 2017, issued as US 10188615

Continuation of 15260127, filed Sep 8, 2016, issued as US 9737496

Continuation of 14631763, filed Feb 25, 2015, issued as US 9458088

Continuation of 14631779, filed Feb 25, 2015

Continuation of 13111679, filed May 19, 2011, issued as US 8981153

Continuation of 12287039, filed Oct 3, 2008, issued as US 7982071

Oct 3, 2008 + 20y = Oct 3, 2028

US 7982071(App. 12287039)

Alkoxy Compounds For Disease Treatment

Filing Date

Oct 3, 2008

Earliest Effective Filing

Oct 3, 2008

Issue Date

Jul 19, 2011

PTA

+413 days

Calculated Expiration

Nov 20, 2029

Oct 3, 2008 + 20y + 413d PTA = Nov 20, 2029

Who owns this patent?

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.